Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cronos Group Inc (CRON.TO)

Cronos Group Inc (CRON.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cronos Group Inc 4491 Concession Rd 12 Stayner ON L0M 1S0 CAN

https://www.thecronosgroup.com P: 416-504-0004

Sector:

Medical

Description:

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Key Statistics

Overview:

Market Capitalization, $K 1,364,584
Shares Outstanding, K 379,051
% of Institutional Shareholders 4.31%

Financials:

Annual Sales, $ 117,615 K
Annual Net Income, $ 41,080 K
Last Quarter Sales, $ 36,339 K
Last Quarter Net Income, $ 25,958 K

Growth:

1-Year Return 20.96%
3-Year Return 35.34%
5-Year Return -72.03%
5-Year Revenue Growth 37.71%
5-Year Earnings Growth -49.44%

Per-Share Information:

Most Recent Earnings 0.07 on 11/06/25
Next Earnings Date 02/27/25
Earnings Per Share ttm 0.11
EPS Growth vs. Prev Year -191.67%
Dividend Payout Ratio 0.00%

CRON.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 30.96
Price/Earnings to Growth N/A
Return-on-Equity % 3.34%
Return-on-Assets % 3.06%
Profit Margin % 34.93%
Debt/Equity 0.00
Price/Sales 6.89
Price/Book 0.91
Book Value/Share 3.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar